Currently, Michael T. Sweeney occupies the position of Senior Vice President-Clinical Development at Resverlogix Corp.

In the past Dr. Sweeney held the position of Senior Director-Urology Global Medial Group Leader at Pfizer Inc., Vice President-Medical Affairs of CV Therapeutics, Inc., Chief Medical Officer, VP-Research & Development at Assertio Therapeutics, Inc. and Senior Clinical Pharmacologist at Zeneca Group Plc.

Dr. Sweeney received a doctorate from The University of Liverpool.